Literature DB >> 24136621

Contractile responses to rat urotensin II in resting and depolarized basilar arteries.

Cristina Porras-González1, Juan Ureña, Juan José Egea-Guerrero, Elena Gordillo-Escobar, Francisco Murillo-Cabezas, María del Carmen González-Montelongo, María Angeles Muñoz-Sánchez.   

Abstract

The effects of human urotensin II (hUII) on the vascular tone of different animal species has been studied extensively. However, little has been reported on the vasoactive effects of rat urotensin (rUII) in murine models. The aim of the present study was to investigate the effects of rUII on vasoreactivity in rat basilar arteries. Basilar arteries from adult male Wistar rats (300-350 g) were isolated, cut in rings, and mounted on a small vessel myograph to measure isometric tension. rUII concentrations were studied in both resting and depolarized state. To remove endothelial nitric oxide effects from the rUII response, we treated selected arterial rings with Nω-nitro-L-arginine methyl ester (L-NAME). 10 μM rUII produced a potent vasoconstrictor response in rat basilar arteries with intact endothelium, while isometric forces remained unaffected in arterial rings treated with lower rUII concentrations. Although L-NAME did not have a significant effect on 10 μM rUII-evoked contraction, it slightly increased arterial ring contraction elicited by 1 μM rUII. In depolarized arteries, dose-dependent rUII increased depolarization-induced contractions. This effect was suppressed by L-NAME. Our results show that the rat basilar artery has a vasoconstrictor response to rUII. The most potent vasoconstrictor effect was produced by lower doses of rUII (0.1 and 1 μM) in depolarized arteries with intact endothelium. This effect could facilitate arterial vasospasm in vascular pathophysiological processes such as subarachnoid hemorrhage and hypertension, when sustained depolarization and L-type Ca(2+) channel activation are present.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136621     DOI: 10.1007/s13105-013-0293-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  28 in total

Review 1.  Calcium-antagonist drugs.

Authors:  D R Abernethy; J B Schwartz
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

2.  Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.

Authors:  S A Douglas; A C Sulpizio; V Piercy; H M Sarau; R S Ames; N V Aiyar; E H Ohlstein; R N Willette
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle.

Authors:  C D Benham; R W Tsien
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

4.  Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction.

Authors:  Miguel Fernández-Tenorio; Cristina Porras-González; Antonio Castellano; Alberto Del Valle-Rodríguez; José López-Barneo; Juan Ureña
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Endothelium-dependent responses of cerebral arterioles to adenosine 5'-diphosphate.

Authors:  W G Mayhan
Journal:  J Vasc Res       Date:  1992 Sep-Oct       Impact factor: 1.934

7.  Increase in functional Ca2+ channels in cerebral smooth muscle with renal hypertension.

Authors:  J M Simard; X Li; K Tewari
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

8.  Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog.

Authors:  D R Harder; P Dernbach; A Waters
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

Authors:  D Pearson; J E Shively; B R Clark; I I Geschwind; M Barkley; R S Nishioka; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines.

Authors:  Patrick Ziltener; Célia Mueller; Bénédicte Haenig; Michael W Scherz; Oliver Nayler
Journal:  J Recept Signal Transduct Res       Date:  2002 Feb-Nov       Impact factor: 2.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.